QSAM Biosciences Announces Reverse Stock Split Effective March 10, 2022 Austin, Texas, March 09, 2022 (GLOBE NEWSWIRE) -- QSAM Biosciences, Inc. (the “Company”) (OTCQB: QSAM), a company developing next-generation therapeutic radiopharmaceuticals, including...

Draganfly Announces New CUSIP Number, Consolidation and ISIN Number in connection with Listing on The Nasdaq Los Angeles, CA., July 27, 2021 (GLOBE NEWSWIRE) -- Draganfly Inc. (OTCQB: DFLYF) (CSE: DFLY) (FSE: 3U8) (“Draganfly” or the “Company”), Draganfly announced today that in connection with the...